by Philippa Shelton | Aug 11, 2023 | VHH Resources, VHHs
From monoclonals to bi-specifics: Harnessing the transformative power of VHHs to supercharge IgG therapeutics Since their discovery over thirty years ago, monoclonal antibodies (mAbs) based on Immunoglobulin G (IgG) have transformed the diagnosis and treatment of many...
by Philippa Shelton | Aug 7, 2023 | Careers
Henry Nell Laboratory Assistant Why did you join Isogenica? “I was on my gap year and wanted to gain some practical lab experience before I went off to Newcastle University to study pharmacology. I reached out to Isogenica to ask if I could get some lab...
by Philippa Shelton | May 2, 2023 | Careers
Victoria Palmer Laboratory Facilities Manager When did you join Isogenica?“In April 2013, I joined Isogenica as the company’s first Laboratory Assistant. I’ve been here ever since and am now the Laboratory Facilities Manager.” What does a typical day at work look like...
by Philippa Shelton | Nov 7, 2022 | Welcome
PEGS 2022: Isogenica showcases plans for implementing machine learning tools Isogenica is attending PEGS Europe: Protein and Antibody Engineering Summit, 14-16th November 2022 Isogenica is delighted to announce we’re attending PEGS Europe 2022. ...
by Philippa Shelton | Nov 4, 2022 | Welcome
Isogenica VHH antibodies used in potential therapy for heart failure Our VHH antibodies have been put to the test as a potential new therapy for heart failure in an early-stage study from AstraZeneca published in Nature Communications. In a step forward for...